Form D · Biotechnology
SymbioCellTech, LLC
Salt Lake City, UT · CIK 0001575304
Offering snapshot reported Aug 28, 2017 · SEC filing
- Reported sold
- $286K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2017 | Initial | $286,050 | No comparison | 3 | SEC filing |
| Jun 30, 2016 | Initial | $1,912,600 | No comparison | 4 | SEC filing |
| Jun 5, 2014 | Amendment | $2,555,000 | $2,355,000vs Mar 21, 2014 | 7 | SEC filing |
| Mar 21, 2014 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-293576
Source: Form D, filed Aug 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Gardner | Director |
| Anna Gooch | Director, Executive |
| Phil Holmes | Director |
| Robert Maddock, Iii | Director |
| Robert Maddock, Llc | Director |
| Susan Mc Keever | Director, Executive |
| George Reiss | Director |
| Christof Westenfelder | Director, Executive, Promoter |
| Axel Zander | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
615 Arapeen, Suite 210
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108